Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
25.8M
-
Shares change
-
-12.3K
-
Total reported value, excl. options
-
$325M
-
Value change
-
-$305K
-
Number of buys
-
29
-
Number of sells
-
-47
-
Price
-
$12.60
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2017
101 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q4 2017.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.8M shares
of 37.4M outstanding shares and own 69.02% of the company stock.
Largest 10 shareholders include NWQ Investment Management Company, LLC (3.7M shares), FRANKLIN RESOURCES INC (2.72M shares), WYNNEFIELD CAPITAL INC (2.68M shares), DIMENSIONAL FUND ADVISORS LP (2.32M shares), BlackRock Inc. (1.87M shares), Vanguard Group Inc (1.36M shares), ROYCE & ASSOCIATES LP (1.22M shares), HEARTLAND ADVISORS INC (849K shares), ROYAL BANK OF CANADA (773K shares), and THOMSON HORSTMANN & BRYANT INC (741K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.